Skip to content
← Home
Canonical · Report

Valeant: The Pharmaceutical Enron?

Andrew Left / Citron Research · 2015

"Valeant used a specialty pharmacy (Philidor) to fabricate sales, echoing Enron-style channel stuffing."

The idea

In 2015, Citron Research published a report comparing Valeant Pharmaceuticals to Enron, triggering a massive collapse in the stock. Valeant had been using a secret network of captive pharmacies to artificially inflate drug prices and force insurance payouts.

Why it works
The takeaway — recall it first
Further reading

Read more about the topic

Up NextSuggested: Continues the theme of Fraud & Short Cases

Enron Short Thesis

"Enron's returns didn't cover its cost of capital and its accounting was opaque; the equity was worthless."

Jim Chanos / Kynikos · ResearchContinue→
Listen
0 / 2